424B5PYXSCIK 0001782223

Pyxis Oncology, Inc.

Name: SEC EDGAR filing 0001437749-26-031480
Creator: Pyxis Oncology, Inc.
License: https://www.usa.gov/government-works

Prospectus supplement (424B5) filed September 29, 2026.

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Open the filing on SEC.gov

Filing facts

Accession number: 0001437749-26-031480
Filer: Pyxis Oncology, Inc.
Ticker: PYXS
CIK: 0001782223
Form type: 424B5
Form description: Prospectus supplement
Filed at: September 29, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 30, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Pyxis Oncology, Inc.

See all 45 filings from Pyxis Oncology, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1782223/000143774926031480/0001437749-26-031480-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Pyxis Oncology, Inc. (0001782223) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.